Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FTNT vs MRNA✓SelectedUSD · MRNAFTNT vs MRNA performance historyLatest closeAs of-5.25%11/20
Stock and ETF performance explorer

FTNT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+88.3%
MRNA return
-27.3%
Excess return
+115.5%
Maximum drawdown
-39.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.2%-2.2%-3.1%-5.1%
7D-2.1%-12.7%+10.6%-1.5%
30D-28.4%-20.7%-7.8%-27.8%
3M-17.4%+46.3%-63.7%-19.4%
6M-4.2%+305.2%-309.4%-18.4%
YTD+56.9%+561.2%-504.4%+20.7%
1Y+59.6%+772.1%-712.5%+16.5%
3Y+140.0%+147.0%-7.0%+102.8%
All+88.3%-27.3%+115.5%+99.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling